Dr. Torres-Yaghi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3800 Reservoir Rd Nw
Department Of Neurology
Washington, DC 20007Phone+1 202-444-2000
Education & Training
- MedStar Health Georgetown UniversityResidency, Neurology, 2012 - 2015
- MedStar Health Georgetown University (Baltimore)Internship, Internal Medicine, 2011 - 2012
- George Washington University School of Medicine and Health SciencesClass of 2011
Certifications & Licensure
- DC State Medical License 2015 - 2027
- VA State Medical License 2015 - 2026
- MD State Medical License 2015 - 2023
- American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- Comparative Safety of Istradefylline Among Parkinson Disease Adjunctive Therapies: A Systematic Review and Meta-analysis of Randomized Controlled Studies.Yasar Torres-Yaghi, Joyce Qian, Hannah Cummings, Hiroo Shimoda, Satoru Ito
Clinical Neuropharmacology. 2025-01-13 - 3 citationsOn the Optimal Diagnosis and the Evolving Role of Pimavanserin in Parkinson's Disease Psychosis.Fernando L Pagan, Paul E Schulz, Yasar Torres-Yaghi, Gregory M Pontone
CNS Drugs. 2024-05-01 - Correction to: Screening, Diagnosis, and Management of Parkinson's Disease Psychosis: Recommendations From an Expert Panel.Rajesh Pahwa, Stuart H Isaacson, Gary W Small, Yasar Torres-Yaghi, Fernando Pagan
Neurology and Therapy. 2023-10-01
Press Mentions
- Kyowa Kirin to Present a Safety Meta-Analysis of NOURIANZ® (Istradefylline) and Other Parkinson's Disease Add-on TherapiesApril 13th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: